Citation: Gr. Lichtenstein, Is infliximab effective for induction of remission in patients with ulcerative colitis?, INFLAMM B D, 7(2), 2001, pp. 89-93
Citation: Me. Blam et al., Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: Current and future perspectives, AM J GASTRO, 96(7), 2001, pp. 1977-1997
Authors:
Su, CG
Stein, RB
Lewis, JD
Lichtenstein, GR
Citation: Cg. Su et al., Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?, DIG LIVER D, 32(6), 2000, pp. 518-531
Citation: Gr. Lichtenstein, Chemokines and cytokines in inflammatory bowel disease and their application to disease treatment, CURR OPIN G, 16(1), 2000, pp. 83-88
Citation: Jd. Lewis et al., Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma, GASTROENTY, 118(6), 2000, pp. 1018-1024
Authors:
Gardiner, MF
Long, WB
Haskal, ZJ
Lichtenstein, GR
Citation: Mf. Gardiner et al., Upper gastrointestinal hemorrhage secondary to erosion of a biliary wallstent in a woman with pancreatic cancer, ENDOSCOPY, 32(8), 2000, pp. 661-663
Authors:
Lichtenstein, GR
Yang, YX
Nunes, FA
Lewis, JD
Tuchman, M
Tino, G
Kaiser, LR
Palevsky, HI
Kotloff, RM
Furth, EE
Bavaria, JE
Stecker, MM
Kaplan, P
Berry, GT
Citation: Gr. Lichtenstein et al., Fatal hyperammonemia after orthotopic lung transplantation, ANN INT MED, 132(4), 2000, pp. 283-287